Patent · US Active

Immunoprotective influenza antigen and its use in vaccination

US7993652B2 · kind B2 · utility

12Cited by

5References

30Claims

0Family size

Assignee

FVlaams Interuniversitair Instituut Voors Biotechnologie · BE

Inventors

Sabine Neirynck · Lokeren, BE
Willy Min Jou · Laarne, BE
Walter Fiers · Laarne, BE

Key dates

Filing date	Jun 7, 2010
Grant date	Aug 9, 2011
Priority date	—
Expiry date	Jun 7, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/16122
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to an influenza antigen, comprising a fusion product of at least the extracellular part of a conserved influenza membrane protein or a functional fragment thereof and a presenting carrier, which may be a presenting (poly)peptide or a non-peptidic structure, such as glycans, peptide mimetics, synthetic polymers. The invention further relates to a vaccine against influenza, comprising at least an antigen of the invention, optionally in the presence of one or more excipients. The invention also relates to use of the antigen, a method for preparing the antigen and acceptor cells expressing the antigen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.